Mitochondrial DNA content is decreased in autosomal dominant optic atrophy

Neurology

Volumn 64, Issue 6, 2005, Pages 966-972

  Kim, J Y ^b   Hwang, J M ^b   Ko, H S ^b   Seong, M W ^b   Park, B J ^b   Park, S S ^a  

^a Seoul National University Hospital   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

ADOLESCENT; ADULT; ARTICLE; AUTOSOMAL DOMINANT OPTIC ATROPHY; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SPLICING; FEMALE; GENE; GENE DUPLICATION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; HUMAN; MALE; MISSENSE MUTATION; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; OPA1 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 15244364005     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000157282.76715.B1     Document Type: Article

References (37)

1. Votruba M, Thiselton D, Bhattacharya SS. Optic disc morphology of patients with OPA1 autosomal dominant optic atrophy. Br J Ophthalmol 2003;87:48-53.
2. Johnston PB, Gaster RN, Smith VC, Tripathi RC. A clinicopathologic study of autosomal dominant optic atrophy. Am J Ophthalmol 1979;88: 868-875.
3. Kjer P, Jensen OA, Klinken L. Histopathology of eye, optic nerve and brain in a case of dominant optic atrophy. Acta Ophthalmol 1983;61: 300-312.
4. Alexander C, Votruba M, Pesch UE, et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet 2000;26:211-215.
5. Delettre C, Lenaers G, Griffoin JM, et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 2000;26:207-210.
6. Delettre C, Griffoin JM, Kaplan J, et al. Mutation spectrum and splicing variants in the OPA1 gene. Hum Genet 2001;109:584-591.
7. Pesch UE, Leo-Kottler B, Mayer S, et al. OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance. Hum Mol Genet 2001;10:1359-1368.
8. Thiselton DL, Alexander C, Morris A, et al. A frameshift mutation in exon 28 of the OPA1 gene explains the high prevalence of dominant optic atrophy in the Danish population: evidence for a founder effect. Hum Genet 2001;109:498-502.
9. Toomes C, Marchbank NJ, Mackey DA, et al. Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy. Hum Mol Genet 2001;10:1369-1378.
10. Thiselton DL, Alexander C, Taanman JW, et al. A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy. Invest Ophthalmol Vis Sci 2002;43:1715-1724.
11. Baris O, Delettre C, Amati-Bonneau P, et al. Fourteen novel OPA1 mutations in autosomal dominant optic atrophy including two de novo mutations in sporadic optic atrophy. Hum Mutat 2003;21:656.
12. Shimizu S, Mori N, Kishi M, et al. A novel mutation in the OPA1 gene in a Japanese patient with optic atrophy. Am J Ophthalmol 2003;135: 256-257.
13. Yamada T, Hayasaka S, Matsumoto M, et al. OPA1 gene mutations in Japanese patients with bilateral optic atrophy unassociated with mitochondrial DNA mutations at nt 11778, 3460, and 14484. Jpn J Ophthalmol 2003;47:409-411.
14. Olichon A, Emorine LJ, Descoins E, et al. The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space. FEBS Lett 2002;523:171-176.
15. Olichon A, Baricault L, Gas N, et al. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem 2003;278:7743-7746.
16. den Dunnen JT, Antonarakis SE. Nomenclature for the description of human sequence variations. Hum Genet 2001;109:121-124.
17. Asano K, Nakamura M, Sato T, et al. Age dependency of mitochondrial DNA decrease differs in different tissues of rat. J Biochem 1993;114: 303-306.
18. Barrientos A, Casademont J, Cardellach F, et al. Reduced steady-state levels of mitochondrial RNA and increased mitochondrial DNA amount in human brain with aging. Brain Res Mol Brain Res 1997;52:284-289.
19. Barazzoni R, Short KR, Nair KS. Effects of aging on mitochondrial DNA copy number and cytochrome c oxidase gene expression in rat skeletal muscle, liver, and heart. J Biol Chem 2000;275:3343-3347.
20. Anderson S, Bankier AT, Barrell BG, et al. Sequence and organization of the human mitochondrial genome. Nature 1981;290:457-465.
21. Shapiro MB, Senapathy P. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res 1987;15:7155-7174.
22. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996;6:986-994.
23. Lewin SR, Vesanen M, Kostrikis L, et al. Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy. J Virol 1999;73:6099-6103.
24. von Wurmb-Schwark N, Higuchi R, Fenech AP, et al. Quantification of human mitochondrial DNA in a real time PCR. Forensic Sci Int 2002; 126:34-39.
25. de Graaf AO, van den Heuvel LP, Dijkman HB, et al. Bcl-2 prevents loss of mitochondria in CCCP-induced apoptosis. Exp Cell Res 2004; 299:533-540.
26. Wallace DC, Lott MT, Brown MD, Kerstann K. Mitochondria and neuro-ophthalmologic diseases. In: Scrive CR, Beaudet AL, Sly WS, et al., eds. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill, 2001:2425-2509.
27. Saada A, Shaag A, Mandel H, et al. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet 2001;29: 342-344.
28. Mandel H, Szargel R, Labay V, et al. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet 2001;29:337-441.
29. DiMauro S. Mitochondrial diseases. Biochim Biophys Acta 2004;1658: 80-88.
30. Ochs S, Hollingsworth D. Dependence of fast axoplasmic transport in nerve on oxidative metabolism. J Neurochem 1971;18:107-114.
31. Sabri MI, Ochs S. Relation of ATP and creatine phosphate to fast axoplasmic transport in mammalian nerve. J Neurochem 1972;19: 2821-2828.
32. Klivenyi P, Karg E, Rozsa C, et al. Alpha-tocopherol/lipid ratio in blood is decreased in patients with Leber's hereditary optic neuropathy and asymptomatic carriers of the 11778 mtDNA mutation. J Neurol Neurosurg Psychiatry 2001;70:359-362.
33. Esposito LA, Melov S, Panov A, Cottrell BA, Wallace DC. Mitochondrial disease in mouse results in increased oxidative stress. Proc Natl Acad Sci USA 1999;96:4820-4825.
34. Marchbank NJ, Craig JE, Leek JP, et al. Deletion of the OPA1 gene in a dominant optic atrophy family: evidence that haploinsufficiency is the cause of disease. J Med Genet 2002;39:e47.
35. Kerrison JB, Arnould VJ, Ferraz Sallum JM, et al. Genetic heterogeneity of dominant optic atrophy, Kjer type: identification of a second locus on chromosome 18q12.2-12.3. Arch Ophthalmol 1999;117:805-810.
36. Praefcke GJ, McMahon HT. The dynamin superfamily: universal membrane tubulation and fission molecules? Nat Rev Mol Cell Biol 2004;5: 133-147.
37. Delettre C, Lenaers G, Pelloquin L, et al. OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease. Mol Genet Metab 2002;75: 97-107.